RONIT SHARMA: Open Payments
NPI 1780270538 · BRYN MAWR, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,633 in 123 payments from 14 companies in 2025. Trend: 2023 $16,893 · 2024 $12,214 · 2025 $8,633
Speaker / faculty: $5,625Food & beverage: $2,739Travel & lodging: $260Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $6,434 |
| Axsome Therapeutics, Inc. | 17 | $420 |
| Vanda Pharmaceuticals Inc. | 14 | $390 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $389 |
| Otsuka America Pharmaceutical, Inc. | 11 | $282 |
| Neurocrine BioSciences, Inc. | 6 | $255 |
| Alkermes, Inc. | 8 | $151 |
| E.R. Squibb & Sons, L.L.C. | 4 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $67 |
| Lundbeck LLC | 2 | $59 |
Products named: VRAYLAR, FANAPT, Auvelity, CAPLYTA, REXULTI, INGREZZA, ARISTADA, COBENFY.
Industry payments across PA — which companies pay providers there.
